There is a need for new antifungal agents, mainly due to increased incidence of invasive fungal infections (IFI), high frequency of associated morbidity and mortality and limitations of the current antifungal agents (e.g., toxicity, drug–drug interactions, and resistance). The clinically available antifungals for IFI are restricted to four main classes: polyenes, flucytosine, triazoles, and echinocandins. Several antifungals are hampered by multiple resistance mechanisms being present in fungi. Consequently, novel antifungal agents with new targets and modified chemical structures are required to combat fungal infections. This review will describe novel antifungals, with a focus on the Aspergillus species.
CITATION STYLE
Vahedi-Shahandashti, R., & Lass-Flörl, C. (2020). Novel antifungal agents and their activity against aspergillus species. Journal of Fungi. MDPI AG. https://doi.org/10.3390/jof6040213
Mendeley helps you to discover research relevant for your work.